Assessment of the effectiveness of additional Risk Minimisation Measures (aRMMs) among pharmacists for provision of Estradiol hemihydrate 10 micrograms vaginal tablets in a community pharmacy settingFirst published 29/07/2024 Last updated 29/07/2024 EU PAS number: EUPAS1000000274StudyFinalised